About Naked Biome
Naked Biome was a Healthcare company based in San Francisco (United States) founded in 2015 by Emma Taylor. It develops genomics tools for treating skin diseases through microbiome research and therapeutics. It operates on a B2B model. Naked Biome has raised $7.76 million across 2 funding rounds from investors including LEO Pharma. Its chief executive is Emma Taylor. The company is recorded as dissolved. Naked Biome offers products and services including Drug Discovery Platform and Probiotic Treatments. Its focus areas include Biotech, Skin Health, Disease Treatment and Genomics. Its competitors include Bio Rad, Siemens Healthineers, Merck, Quanterix and Revance Therapeutics and 4 more; 5 of its 9 listed competitors have raised funding.
Company details
Naked Biome specializes in microbiome-based therapeutics for skin conditions like acne and eczema. They use advanced genomics platforms and next-generation sequencing to identify microbial signatures and create treatments. Based in San Jose, California, they collaborate with experts and participate in programs like Illumina Accelerator to advance drug discovery and restore skin health.
- Headquarters San Francisco, United States
- Founders Emma Taylor
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nakedbiome.com
- Social X Facebook
- Total Equity Funding$7.76M (USD)
in 2 rounds
- Latest Funding Round$1.66M (USD), Seed
Apr 2018
- Investors
Products & Services of Naked Biome
Naked Biome offers a comprehensive portfolio of products and services, including Drug Discovery Platform and Probiotic Treatments.
Uses sequencing to profile skin microbiomes for disease treatment development.
Develops microbiome-based solutions for skin conditions like acne and eczema.
Funding Insights of Naked Biome
Naked Biome has successfully raised a total of $7.76M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.66 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.76M
- Total Rounds 2
- Last Round Seed — $1.66M
- First Round $6.11M
(Apr 2017)
- Investors Count 1
All 2 funding rounds of Naked Biome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2018 | $1.66M | Seed | – | LEO Pharma | – |
| Apr 2017 | $6.11M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Naked Biome
Naked Biome has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LEO Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of drugs for treating dermatology diseases | 1908 | leo-pharma.com | Copenhagen, Denmark |
Investor details for Naked Biome
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Naked Biome
2 people are tracked at Naked Biome (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Emma Taylor | Co-Founder, CEO | Leadership |
Rafi Bamdad | Investor | Team |
Complete people profiles for Naked Biome
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Naked Biome
3 dated milestones of Naked Biome across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Naked Biome is founded.
- Funding First funding round of $6.1M.
- Funding Latest funding round, Seed, of $1.7M.
Competitors of Naked Biome
Naked Biome has 9 listed competitors in our database, 5 of them funded. They include Bio Rad, Siemens Healthineers, Merck, Quanterix and Revance Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | |
| siemens-healthineers.com | 1847 | Erlangen, Germany | – | 66,000 | AI-based medical diagnostics are developed for healthcare applications. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| revance.com | 2002 | Newark, United States | $154.56M | 597 | Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | |
| novozymes.com | 2000 | Bagsvaerd, Denmark | – | 6,781 | Biosolutions and enzymes are developed for biotechnology applications across industries. | |
| evelobio.com | 2015 | Cambridge, United States | $166.5M | 117 | Therapeutics for inflammatory diseases, COVID-19, and cancer are developed. | |
| castlecreekpharma.com | 2015 | Basking Ridge, United States | $663.15M | 72 | Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. |
Detailed competitors of Naked Biome
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Naked Biome
The website of Naked Biome (nakedbiome.com) receives about 4K visits a month.
- Monthly visits4K
▲ 887.5% vs previous month
Top companies in Dermatology
10 companies that operate in the same segment as Naked Biome (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Naked Biome
Complete news archive for Naked Biome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naked Biome
Naked Biome was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Naked Biome is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Emma Taylor is the current CEO of Naked Biome. They have also founded this company.
Naked Biome is a funded company, having raised a total of $7.76M across 2 funding rounds to date. The company's 1st funding round was a Seed of $6.11M, raised on Apr 2017.
Naked Biome specializes in microbiome-based therapeutics for skin conditions like acne and eczema. They use advanced genomics platforms and next-generation sequencing to identify microbial signatures and create treatments. Based in San Jose, California, they collaborate with experts and participate in programs like Illumina Accelerator to advance drug discovery and restore skin health.
Naked Biome's top competitors include Revance Therapeutics, Novozymes and Biocare Medical.
Naked Biome offers Drug Discovery Platform and Probiotic Treatments.
Naked Biome has 1 investor. Key investors include LEO Pharma.